{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:44:01Z","timestamp":1793317441842,"version":"4.5.0"},"reference-count":179,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T00:00:00Z","timestamp":1651190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30-AG024824"],"award-info":[{"award-number":["P30-AG024824"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30-CA046592"],"award-info":[{"award-number":["P30-CA046592"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1-TR00457"],"award-info":[{"award-number":["UL1-TR00457"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015394","name":"American Society for Transplantation and Cellular Therapy","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015394","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Metastasis Rev"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10555-022-10033-7","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T16:03:43Z","timestamp":1651248223000},"page":"367-382","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Host-microbe interactions and outcomes in multiple myeloma and hematopoietic stem cell transplantation"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9295-9750","authenticated-orcid":false,"given":"Matthew J.","family":"Pianko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0009-5815","authenticated-orcid":false,"given":"Jonathan L.","family":"Golob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,29]]},"reference":[{"issue":"7402","key":"10033_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"Human Microbiome Project Consortium","year":"2012","unstructured":"Human Microbiome Project Consortium. (2012). Structure, function and diversity of the healthy human microbiome. Nature, 486(7402), 207\u2013214. https:\/\/doi.org\/10.1038\/nature11234","journal-title":"Nature"},{"key":"10033_CR2","doi-asserted-by":"publisher","unstructured":"Ley, R. E., Hamady, M., Lozupone, C., Turnbaugh, P. J., Ramey, R. R., Bircher, J. S., \u2026 Gordon, J. I. (2008). Evolution of mammals and their gut microbes. Science, 320(5883), 1647\u20131651. https:\/\/doi.org\/10.1126\/science.1155725","DOI":"10.1126\/science.1155725"},{"key":"10033_CR3","unstructured":"Bik, E. M. (2016). The hoops, hopes, and hypes of human microbiome research. The Yale journal of biology and medicine, 89(3), 363\u2013373. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27698620. Accessed 3 Jan 2022"},{"issue":"1","key":"10033_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2014.03.011","volume":"157","author":"Y Belkaid","year":"2014","unstructured":"Belkaid, Y., & Hand, T. W. (2014). Role of the microbiota in immunity and inflammation. Cell, 157(1), 121\u2013141. https:\/\/doi.org\/10.1016\/j.cell.2014.03.011","journal-title":"Cell"},{"issue":"3","key":"10033_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cell.2016.01.013","volume":"164","author":"R Sender","year":"2016","unstructured":"Sender, R., Fuchs, S., & Milo, R. (2016). Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell, 164(3), 337\u2013340. https:\/\/doi.org\/10.1016\/j.cell.2016.01.013","journal-title":"Cell"},{"key":"10033_CR6","doi-asserted-by":"publisher","unstructured":"Yatsunenko, T., Rey, F. E., Manary, M. J., Trehan, I., Dominguez-Bello, M. G., Contreras, M., \u2026 Gordon, J. I. (2012). Human gut microbiome viewed across age and geography. Nature, 486(7402), 222\u2013227. https:\/\/doi.org\/10.1038\/nature11053","DOI":"10.1038\/nature11053"},{"key":"10033_CR7","doi-asserted-by":"publisher","unstructured":"Rothschild, D., Weissbrod, O., Barkan, E., Kurilshikov, A., Korem, T., Zeevi, D., \u2026 Segal, E. (2018). Environment dominates over host genetics in shaping human gut microbiota. Nature, 555(7695), 210\u2013215. https:\/\/doi.org\/10.1038\/nature25973","DOI":"10.1038\/nature25973"},{"key":"10033_CR8","doi-asserted-by":"publisher","unstructured":"David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., \u2026 Turnbaugh, P. J. (2014). Diet rapidly and reproducibly alters the human gut microbiome. Nature, 505(7484), 559\u2013563. https:\/\/doi.org\/10.1038\/nature12820","DOI":"10.1038\/nature12820"},{"key":"10033_CR9","unstructured":"Iebba, V., Totino, V., Gagliardi, A., Santangelo, F., Cacciotti, F., Trancassini, M., \u2026 Schippa, S. (2016). Eubiosis and dysbiosis: The two sides of the microbiota. The new microbiologica, 39(1), 1\u201312. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26922981. Accessed 3 Jan 2022"},{"issue":"6","key":"10033_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1053\/j.gastro.2014.02.009","volume":"146","author":"AD Kostic","year":"2014","unstructured":"Kostic, A. D., Xavier, R. J., & Gevers, D. (2014). The microbiome in inflammatory bowel disease: Current status and the future ahead. Gastroenterology, 146(6), 1489\u20131499. https:\/\/doi.org\/10.1053\/j.gastro.2014.02.009","journal-title":"Gastroenterology"},{"issue":"10","key":"10033_CR11","doi-asserted-by":"publisher","first-page":"4190","DOI":"10.1172\/JCI72330","volume":"124","author":"SR Dalal","year":"2014","unstructured":"Dalal, S. R., & Chang, E. B. (2014). The microbial basis of inflammatory bowel diseases. The Journal of clinical investigation, 124(10), 4190\u20134196. https:\/\/doi.org\/10.1172\/JCI72330","journal-title":"The Journal of clinical investigation"},{"key":"10033_CR12","doi-asserted-by":"publisher","unstructured":"Lloyd-Price, J., Arze, C., Ananthakrishnan, A. N., Schirmer, M., Avila-Pacheco, J., Poon, T. W., \u2026 Huttenhower, C. (2019). Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature, 569(7758), 655\u2013662. https:\/\/doi.org\/10.1038\/s41586-019-1237-9","DOI":"10.1038\/s41586-019-1237-9"},{"issue":"2","key":"10033_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1097\/BOR.0000000000000574","volume":"31","author":"C Dehner","year":"2019","unstructured":"Dehner, C., Fine, R., & Kriegel, M. A. (2019). The microbiome in systemic autoimmune disease: Mechanistic insights from recent studies. Current opinion in rheumatology, 31(2), 201\u2013207. https:\/\/doi.org\/10.1097\/BOR.0000000000000574","journal-title":"Current opinion in rheumatology"},{"key":"10033_CR14","doi-asserted-by":"crossref","unstructured":"Paun, A., Yau, C., & Danska, J. S. (2017). The influence of the microbiome on type 1 diabetes. The Journal of Immunology. Retrieved from https:\/\/www.jimmunol.org\/content\/198\/2\/590.short. Accessed 3 Jan 2022","DOI":"10.4049\/jimmunol.1601519"},{"key":"10033_CR15","doi-asserted-by":"publisher","unstructured":"Udayappan, S., Manneras-Holm, L., Chaplin-Scott, A., Belzer, C., Herrema, H., Dallinga-Thie, G. M., \u2026 Nieuwdorp, M. (2016). Oral treatment with Eubacterium hallii improves insulin sensitivity in db\/db mice. NPJ Biofilms Microbiomes, 2, 16009. https:\/\/doi.org\/10.1038\/npjbiofilms.2016.9","DOI":"10.1038\/npjbiofilms.2016.9"},{"key":"10033_CR16","doi-asserted-by":"publisher","unstructured":"Wu, H., Esteve, E., Tremaroli, V., Khan, M. T., Caesar, R., Manner\u00e5s-Holm, L., \u2026 B\u00e4ckhed, F. (2017). Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nature medicine, 23(7), 850\u2013858. https:\/\/doi.org\/10.1038\/nm.4345","DOI":"10.1038\/nm.4345"},{"issue":"7","key":"10033_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41568-019-0155-3","volume":"19","author":"E Elinav","year":"2019","unstructured":"Elinav, E., Garrett, W. S., Trinchieri, G., & Wargo, J. (2019). The cancer microbiome. Nature reviews. Cancer, 19(7), 371\u2013376. https:\/\/doi.org\/10.1038\/s41568-019-0155-3","journal-title":"Nature reviews. Cancer"},{"key":"10033_CR18","doi-asserted-by":"publisher","unstructured":"Xavier, J. B., Young, V. B., Skufca, J., Ginty, F., Testerman, T., Pearson, A. T., \u2026 Wargo, J. A. (2020). The cancer microbiome: Distinguishing direct and indirect effects requires a systemic view. Trends in cancer research, 6(3), 192\u2013204. https:\/\/doi.org\/10.1016\/j.trecan.2020.01.004","DOI":"10.1016\/j.trecan.2020.01.004"},{"issue":"6","key":"10033_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41571-018-0006-2","volume":"15","author":"B Routy","year":"2018","unstructured":"Routy, B., Gopalakrishnan, V., Daill\u00e8re, R., Zitvogel, L., Wargo, J. A., & Kroemer, G. (2018). The gut microbiota influences anticancer immunosurveillance and general health. Nature reviews. Clinical oncology, 15(6), 382\u2013396. https:\/\/doi.org\/10.1038\/s41571-018-0006-2","journal-title":"Nature reviews. Clinical oncology"},{"issue":"4","key":"10033_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","volume":"33","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan, V., Helmink, B. A., Spencer, C. N., Reuben, A., & Wargo, J. A. (2018). The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy. Cancer Cell, 33(4), 570\u2013580. https:\/\/doi.org\/10.1016\/j.ccell.2018.03.015","journal-title":"Cancer Cell"},{"key":"10033_CR21","doi-asserted-by":"publisher","unstructured":"Yu, A. I., & Chen, G. Y. (2021). The gut microbiome and colorectal cancer. In J. Sun (Ed.), Inflammation, Infection, and Microbiome in Cancers: Evidence, Mechanisms, and Implications (pp. 63\u201396). Cham: Springer International Publishing. https:\/\/doi.org\/10.1007\/978-3-030-67951-4_3","DOI":"10.1007\/978-3-030-67951-4_3"},{"key":"10033_CR22","doi-asserted-by":"publisher","unstructured":"Ren, Z., Li, A., Jiang, J., Zhou, L., Yu, Z., Lu, H., \u2026 Zheng, S. (2019). Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut, 68(6), 1014\u20131023. https:\/\/doi.org\/10.1136\/gutjnl-2017-315084","DOI":"10.1136\/gutjnl-2017-315084"},{"issue":"4","key":"10033_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.4161\/gmic.29599","volume":"5","author":"C Roderburg","year":"2014","unstructured":"Roderburg, C., & Luedde, T. (2014). The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma. Gut microbes, 5(4), 441\u2013445. https:\/\/doi.org\/10.4161\/gmic.29599","journal-title":"Gut microbes"},{"key":"10033_CR24","doi-asserted-by":"publisher","unstructured":"Pushalkar, S., Hundeyin, M., Daley, D., Zambirinis, C. P., Kurz, E., Mishra, A., \u2026 Miller, G. (2018). The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression. Cancer discovery, 8(4), 403\u2013416. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-1134","DOI":"10.1158\/2159-8290.CD-17-1134"},{"key":"10033_CR25","doi-asserted-by":"publisher","unstructured":"Portlock, C. S., Hamlin, P. A., Gerecitano, J. F., Noy, A., Palomba, M. L., Walkley, J., \u2026 Markowitz, A. J. (2015). A positive prospective trial of antibiotic therapy in advanced stage, non-bulky indolent lymphoma. Tumor Microenviron Ther, 2(1), 14\u201318. https:\/\/doi.org\/10.1515\/tumor-2015-0001","DOI":"10.1515\/tumor-2015-0001"},{"issue":"8871","key":"10033_CR26","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/0140-6736(93)91409-f","volume":"342","author":"AC Wotherspoon","year":"1993","unstructured":"Wotherspoon, A. C., Doglioni, C., Diss, T. C., Pan, L., Moschini, A., de Boni, M., & Isaacson, P. G. (1993). Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. The Lancet, 342(8871), 575\u2013577. https:\/\/doi.org\/10.1016\/0140-6736(93)91409-f","journal-title":"The Lancet"},{"key":"10033_CR27","doi-asserted-by":"publisher","unstructured":"Calcinotto, A., Brevi, A., Chesi, M., Ferrarese, R., Garcia Perez, L., Grioni, M., \u2026 Bellone, M. (2018). Microbiota-driven interleukin-17-producing cells and eosinophils synergize to accelerate multiple myeloma progression. Nature communications, 9(1), 4832. https:\/\/doi.org\/10.1038\/s41467-018-07305-8","DOI":"10.1038\/s41467-018-07305-8"},{"key":"10033_CR28","doi-asserted-by":"publisher","unstructured":"Jian, X., Zhu, Y., Ouyang, J., Lei, Q., Xia, J., Zhang, J., \u2026 Zhou, W. (2019). Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen recycling bacteria. Blood, 134(Supplement_1), 688\u2013688. https:\/\/doi.org\/10.1182\/blood-2019-125051","DOI":"10.1182\/blood-2019-125051"},{"key":"10033_CR29","doi-asserted-by":"crossref","unstructured":"Frankel, A. E., Coughlin, L. A., Kim, J., Froehlich, T. W., Xie, Y., Frenkel, E. P., & Koh, A. Y. (2017). Metagenomic shotgun sequencing and unbiased metabolomic profiling identify specific human gut microbiota and metabolites associated with immune checkpoint therapy efficacy in melanoma patients. Neoplasia , 19(10), 848\u2013855. Retrieved from https:\/\/www.sciencedirect.com\/science\/article\/pii\/S1476558617302385. Accessed 3 Jan 2022","DOI":"10.1016\/j.neo.2017.08.004"},{"key":"10033_CR30","doi-asserted-by":"publisher","unstructured":"Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., \u2026 Wargo, J. A. (2018). Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science, 359(6371), 97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236","DOI":"10.1126\/science.aan4236"},{"key":"10033_CR31","doi-asserted-by":"publisher","unstructured":"Chaput, N., Lepage, P., Coutzac, C., Soularue, E., Le Roux, K., Monot, C., \u2026 Carbonnel, F. (2017). Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Annals of oncology: official journal of the European Society for Medical Oncology \/ ESMO, 28(6), 1368\u20131379. https:\/\/doi.org\/10.1093\/annonc\/mdx108","DOI":"10.1093\/annonc\/mdx108"},{"key":"10033_CR32","doi-asserted-by":"publisher","unstructured":"Vetizou, M., Pitt, J. M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., \u2026 Zitvogel, L. (2015). Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science, 350(6264), 1079\u20131084. https:\/\/doi.org\/10.1126\/science.aad1329","DOI":"10.1126\/science.aad1329"},{"key":"10033_CR33","doi-asserted-by":"publisher","unstructured":"Dubin, K., Callahan, M. K., Ren, B., Khanin, R., Viale, A., Ling, L., \u2026 Wolchok, J. D. (2016). Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis. Nature communications, 7, 10391. https:\/\/doi.org\/10.1038\/ncomms10391","DOI":"10.1038\/ncomms10391"},{"key":"10033_CR34","doi-asserted-by":"publisher","unstructured":"Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., \u2026 Goldszmid, R. S. (2013). Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment. Science, 342(6161), 967\u2013970. https:\/\/doi.org\/10.1126\/science.1240527","DOI":"10.1126\/science.1240527"},{"key":"10033_CR35","doi-asserted-by":"publisher","unstructured":"Paulos, C. M., Wrzesinski, C., Kaiser, A., Hinrichs, C. S., Chieppa, M., Cassard, L., \u2026 Restifo, N. P. (2007). Microbial translocation augments the function of adoptively transferred self\/tumor-specific CD8+ T cells via TLR4 signaling. The Journal of clinical investigation, 117(8), 2197\u20132204. https:\/\/doi.org\/10.1172\/JCI32205","DOI":"10.1172\/JCI32205"},{"key":"10033_CR36","doi-asserted-by":"publisher","unstructured":"Schluter, J., Peled, J. U., Taylor, B. P., Markey, K. A., Smith, M., Taur, Y., \u2026 Xavier, J. B. (2020). The gut microbiota is associated with immune cell dynamics in humans. Nature, 588(7837), 303\u2013307. https:\/\/doi.org\/10.1038\/s41586-020-2971-8","DOI":"10.1038\/s41586-020-2971-8"},{"issue":"7610","key":"10033_CR37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda, K., & Littman, D. R. (2016). The microbiota in adaptive immune homeostasis and disease. Nature, 535(7610), 75\u201384. https:\/\/doi.org\/10.1038\/nature18848","journal-title":"Nature"},{"issue":"10","key":"10033_CR38","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.4014\/jmb.1501.01039","volume":"25","author":"M Al-Asmakh","year":"2015","unstructured":"Al-Asmakh, M., & Zadjali, F. (2015). Use of germ-free animal models in microbiota-related research. Journal of microbiology and biotechnology, 25(10), 1583\u20131588. https:\/\/doi.org\/10.4014\/jmb.1501.01039","journal-title":"Journal of microbiology and biotechnology"},{"key":"10033_CR39","doi-asserted-by":"publisher","unstructured":"Johansson, M. E. V., Jakobsson, H. E., Holm\u00e9n-Larsson, J., Sch\u00fctte, A., Ermund, A., Rodr\u00edguez-Pi\u00f1eiro, A. M., \u2026 Hansson, G. C. (2015). Normalization of host intestinal mucus layers requires long-term microbial colonization. Cell Host & Microbe. https:\/\/doi.org\/10.1016\/j.chom.2015.10.007","DOI":"10.1016\/j.chom.2015.10.007"},{"key":"10033_CR40","doi-asserted-by":"publisher","unstructured":"Hapfelmeier, S., Lawson, M. A. E., Slack, E., Kirundi, J. K., Stoel, M., Heikenwalder, M., \u2026 Macpherson, A. J. (2010). Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science, 328(5986), 1705\u20131709. https:\/\/doi.org\/10.1126\/science.1188454","DOI":"10.1126\/science.1188454"},{"key":"10033_CR41","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.3389\/fimmu.2017.01353","volume":"8","author":"M Spiljar","year":"2017","unstructured":"Spiljar, M., Merkler, D., & Trajkovski, M. (2017). The immune system bridges the gut microbiota with systemic energy homeostasis: Focus on TLRs, mucosal barrier, and SCFAs. Frontiers in immunology, 8, 1353. https:\/\/doi.org\/10.3389\/fimmu.2017.01353","journal-title":"Frontiers in immunology"},{"issue":"9","key":"10033_CR42","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1002\/eji.200535244","volume":"36","author":"S Ostman","year":"2006","unstructured":"Ostman, S., Rask, C., Wold, A. E., Hultkrantz, S., & Telemo, E. (2006). Impaired regulatory T cell function in germ-free mice. European journal of immunology, 36(9), 2336\u20132346. https:\/\/doi.org\/10.1002\/eji.200535244","journal-title":"European journal of immunology"},{"key":"10033_CR43","doi-asserted-by":"publisher","unstructured":"Abt, M. C., Osborne, L. C., Monticelli, L. A., Doering, T. A., Alenghat, T., Sonnenberg, G. F., \u2026 Artis, D. (2012). Commensal bacteria calibrate the activation threshold of innate antiviral immunity. Immunity, 37(1), 158\u2013170. https:\/\/doi.org\/10.1016\/j.immuni.2012.04.011","DOI":"10.1016\/j.immuni.2012.04.011"},{"issue":"15","key":"10033_CR44","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1073\/pnas.1102938108","volume":"108","author":"AL Goodman","year":"2011","unstructured":"Goodman, A. L., Kallstrom, G., Faith, J. J., Reyes, A., Moore, A., Dantas, G., & Gordon, J. I. (2011). Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proceedings of the National Academy of Sciences of the United States of America, 108(15), 6252\u20136257. https:\/\/doi.org\/10.1073\/pnas.1102938108","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10033_CR45","doi-asserted-by":"publisher","unstructured":"Ivanov, I. I., Atarashi, K., Manel, N., Brodie, E. L., Shima, T., Karaoz, U., \u2026 Littman, D. R. (2009). Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell, 139(3), 485\u2013498. https:\/\/doi.org\/10.1016\/j.cell.2009.09.033","DOI":"10.1016\/j.cell.2009.09.033"},{"issue":"13","key":"10033_CR46","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1182\/blood-2012-09-378653","volume":"121","author":"P Muranski","year":"2013","unstructured":"Muranski, P., & Restifo, N. P. (2013). Essentials of Th17 cell commitment and plasticity. Blood, 121(13), 2402\u20132414. https:\/\/doi.org\/10.1182\/blood-2012-09-378653","journal-title":"Blood"},{"key":"10033_CR47","doi-asserted-by":"publisher","unstructured":"McAllister, F., Bailey, J. M., Alsina, J., Nirschl, C. J., Sharma, R., Fan, H., \u2026 Leach, S. D. (2014). Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia. Cancer cell, 25(5), 621\u2013637. https:\/\/doi.org\/10.1016\/j.ccr.2014.03.014","DOI":"10.1016\/j.ccr.2014.03.014"},{"key":"10033_CR48","unstructured":"Tartour, E., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E., \u2026 Saut\u00e8s-Fridman, C. (1999). Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer research, 59(15), 3698\u20133704. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10446984. Accessed 3 Jan 2022"},{"key":"10033_CR49","doi-asserted-by":"publisher","unstructured":"Wang, L., Yi, T., Kortylewski, M., Pardoll, D. M., Zeng, D., & Yu, H. (2009). IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. The Journal of experimental medicine, 206(7), 1457\u20131464. jem.20090207 [pii] https:\/\/doi.org\/10.1084\/jem.20090207","DOI":"10.1084\/jem.20090207"},{"issue":"18","key":"10033_CR50","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1182\/blood-2010-05-283895","volume":"116","author":"K Noonan","year":"2010","unstructured":"Noonan, K., Marchionni, L., Anderson, J., Pardoll, D., Roodman, G. D., & Borrello, I. (2010). A novel role of IL-17\u2013producing lymphocytes in mediating lytic bone disease in multiple myeloma. Blood, 116(18), 3554\u20133563. https:\/\/doi.org\/10.1182\/blood-2010-05-283895","journal-title":"Blood"},{"key":"10033_CR51","doi-asserted-by":"publisher","unstructured":"Baxter, N. T., Schmidt, A. W., Venkataraman, A., Kim, K. S., Waldron, C., Schmidt, T. M., & Blaser, M. J. (2019). Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. mBio, 10(1). https:\/\/doi.org\/10.1128\/mBio.02566-18","DOI":"10.1128\/mBio.02566-18"},{"key":"10033_CR52","doi-asserted-by":"publisher","unstructured":"Davis, J. A., Collier, F., Mohebbi, M., Pasco, J. A., Shivappa, N., H\u00e9bert, J. R., \u2026 Loughman, A. (2021). The associations of butyrate-producing bacteria of the gut microbiome with diet quality and muscle health. Gut Microbiome, 2(e2), 1\u201336. https:\/\/doi.org\/10.1017\/gmb.2021.2","DOI":"10.1017\/gmb.2021.2"},{"key":"10033_CR53","doi-asserted-by":"publisher","unstructured":"Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., \u2026 Ganapathy, V. (2009). GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer research, 69(7), 2826\u20132832. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-4466","DOI":"10.1158\/0008-5472.CAN-08-4466"},{"issue":"8","key":"10033_CR54","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jgg.2012.05.008","volume":"39","author":"J Wu","year":"2012","unstructured":"Wu, J., Zhou, Z., Hu, Y., & Dong, S. (2012). Butyrate-induced GPR41 activation inhibits histone acetylation and cell growth. Yi chuan xue bao [Journal of genetics and genomics], 39(8), 375\u2013384. https:\/\/doi.org\/10.1016\/j.jgg.2012.05.008","journal-title":"Yi chuan xue bao [Journal of genetics and genomics]"},{"issue":"1","key":"10033_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1006\/clim.2001.5181","volume":"103","author":"J Padilla","year":"2002","unstructured":"Padilla, J., Leung, E., & Phipps, R. P. (2002). Human B lymphocytes and B lymphomas express PPAR-\u03b3 and are killed by PPAR-\u03b3 agonists. Clinical immunology, 103(1), 22\u201333. https:\/\/doi.org\/10.1006\/clim.2001.5181","journal-title":"Clinical immunology"},{"key":"10033_CR56","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-08-0457","author":"TM Garcia-Bates","year":"2008","unstructured":"Garcia-Bates, T. M., Bernstein, S. H., & Phipps, R. P. (2008). Peroxisome proliferator-activated receptor \u03b3 overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clinical Cancer Research. https:\/\/doi.org\/10.1158\/1078-0432.ccr-08-0457","journal-title":"Clinical Cancer Research"},{"issue":"24","key":"10033_CR57","doi-asserted-by":"publisher","first-page":"10028","DOI":"10.1073\/pnas.87.24.10028","volume":"87","author":"JA Molitor","year":"1990","unstructured":"Molitor, J. A., Walker, W. H., Doerre, S., Ballard, D. W., & Greene, W. C. (1990). NF-kappa B: A family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proceedings of the National Academy of Sciences of the United States of America, 87(24), 10028\u201310032. https:\/\/doi.org\/10.1073\/pnas.87.24.10028","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"10033_CR58","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1017\/S0954422410000247","volume":"23","author":"P Guilloteau","year":"2010","unstructured":"Guilloteau, P., Martin, L., Eeckhaut, V., Ducatelle, R., Zabielski, R., & Van Immerseel, F. (2010). From the gut to the peripheral tissues: The multiple effects of butyrate. Nutrition research reviews, 23(2), 366\u2013384. https:\/\/doi.org\/10.1017\/S0954422410000247","journal-title":"Nutrition research reviews"},{"key":"10033_CR59","doi-asserted-by":"publisher","DOI":"10.1136\/gut.47.3.397","author":"J-P Segain","year":"2000","unstructured":"Segain, J.-P. (2000). Butyrate inhibits inflammatory responses through NFkappa B inhibition: Implications for Crohn\u2019s disease. Gut. https:\/\/doi.org\/10.1136\/gut.47.3.397","journal-title":"Gut"},{"key":"10033_CR60","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.intimp.2017.07.023","volume":"51","author":"C Lee","year":"2017","unstructured":"Lee, C., Kim, B. G., Kim, J. H., Chun, J., Im, J. P., & Kim, J. S. (2017). Sodium butyrate inhibits the NF-kappa B signaling pathway and histone deacetylation, and attenuates experimental colitis in an IL-10 independent manner. International immunopharmacology, 51, 47\u201356. https:\/\/doi.org\/10.1016\/j.intimp.2017.07.023","journal-title":"International immunopharmacology"},{"key":"10033_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/nature04870","author":"M Karin","year":"2006","unstructured":"Karin, M. (2006). Nuclear factor-\u03baB in cancer development and progression. Nature. https:\/\/doi.org\/10.1038\/nature04870","journal-title":"Nature"},{"key":"10033_CR62","doi-asserted-by":"publisher","unstructured":"Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., \u2026 Ohno, H. (2013). Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature, 504(7480), 446\u2013450. https:\/\/doi.org\/10.1038\/nature12721","DOI":"10.1038\/nature12721"},{"issue":"1","key":"10033_CR63","doi-asserted-by":"publisher","first-page":"9742","DOI":"10.1038\/s41598-018-28048-y","volume":"8","author":"C Martin-Gallausiaux","year":"2018","unstructured":"Martin-Gallausiaux, C., B\u00e9guet-Crespel, F., Marinelli, L., Jamet, A., Ledue, F., Blotti\u00e8re, H. M., & Lapaque, N. (2018). Butyrate produced by gut commensal bacteria activates TGF-beta1 expression through the transcription factor SP1 in human intestinal epithelial cells. Scientific reports, 8(1), 9742. https:\/\/doi.org\/10.1038\/s41598-018-28048-y","journal-title":"Scientific reports"},{"issue":"2","key":"10033_CR64","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chom.2016.07.001","volume":"20","author":"M Kim","year":"2016","unstructured":"Kim, M., Qie, Y., Park, J., & Kim, C. H. (2016). Gut microbial metabolites fuel host antibody responses. Cell host & microbe, 20(2), 202\u2013214. https:\/\/doi.org\/10.1016\/j.chom.2016.07.001","journal-title":"Cell host & microbe"},{"key":"10033_CR65","doi-asserted-by":"publisher","unstructured":"Wu, W., Sun, M., Chen, F., Cao, A. T., Liu, H., Zhao, Y., \u2026 Cong, Y. (2017). Microbiota metabolite short-chain fatty acid acetate promotes intestinal IgA response to microbiota which is mediated by GPR43. Mucosal immunology, 10(4), 946\u2013956. https:\/\/doi.org\/10.1038\/mi.2016.114","DOI":"10.1038\/mi.2016.114"},{"key":"10033_CR66","doi-asserted-by":"publisher","unstructured":"Bachem, A., Makhlouf, C., Binger, K. J., de Souza, D. P., Tull, D., Hochheiser, K., \u2026 Bedoui, S. (2019). Microbiota-derived short-chain fatty acids promote the memory potential of antigen-activated CD8+ T cells. Immunity, 51(2), 285-297.e5. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.002","DOI":"10.1016\/j.immuni.2019.06.002"},{"key":"10033_CR67","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki, T., & Kawai, T. (2014). Toll-like receptor signaling pathways. Frontiers in immunology, 5, 461. https:\/\/doi.org\/10.3389\/fimmu.2014.00461","journal-title":"Frontiers in immunology"},{"issue":"7","key":"10033_CR68","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","volume":"16","author":"P Broz","year":"2016","unstructured":"Broz, P., & Dixit, V. M. (2016). Inflammasomes: Mechanism of assembly, regulation and signalling. Nature reviews. Immunology, 16(7), 407\u2013420. https:\/\/doi.org\/10.1038\/nri.2016.58","journal-title":"Nature reviews. Immunology"},{"issue":"6","key":"10033_CR69","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1053\/j.gastro.2014.08.033","volume":"147","author":"B Chassaing","year":"2014","unstructured":"Chassaing, B., Ley, R. E., & Gewirtz, A. T. (2014). Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology, 147(6), 1363\u201377.e17. https:\/\/doi.org\/10.1053\/j.gastro.2014.08.033","journal-title":"Gastroenterology"},{"key":"10033_CR70","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.freeradbiomed.2016.11.011","volume":"105","author":"GY Chen","year":"2017","unstructured":"Chen, G. Y. (2017). Regulation of the gut microbiome by inflammasomes. Free radical biology & medicine, 105, 35\u201340. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2016.11.011","journal-title":"Free radical biology & medicine"},{"key":"10033_CR71","doi-asserted-by":"publisher","unstructured":"Levy, M., Thaiss, C. A., Zeevi, D., Dohnalov\u00e1, L., Zilberman-Schapira, G., Mahdi, J. A., \u2026 Elinav, E. (2015). Microbiota-modulated metabolites shape the intestinal microenvironment by regulating NLRP6 inflammasome signaling. Cell, 163(6), 1428\u20131443. https:\/\/doi.org\/10.1016\/j.cell.2015.10.048","DOI":"10.1016\/j.cell.2015.10.048"},{"key":"10033_CR72","doi-asserted-by":"publisher","unstructured":"Zhao, Y., Chen, F., Wu, W., Sun, M., Bilotta, A. J., Yao, S., \u2026 Cong, Y. (2018). GPR43 mediates microbiota metabolite SCFA regulation of antimicrobial peptide expression in intestinal epithelial cells via activation of mTOR and STAT3. Mucosal Immunology. https:\/\/doi.org\/10.1038\/mi.2017.118","DOI":"10.1038\/mi.2017.118"},{"issue":"6","key":"10033_CR73","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.smim.2013.10.014","volume":"25","author":"D Novick","year":"2013","unstructured":"Novick, D., Kim, S., Kaplanski, G., & Dinarello, C. A. (2013). Interleukin-18, more than a Th1 cytokine. Seminars in immunology, 25(6), 439\u2013448. https:\/\/doi.org\/10.1016\/j.smim.2013.10.014","journal-title":"Seminars in immunology"},{"issue":"5","key":"10033_CR74","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646\u2013674. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","journal-title":"Cell"},{"key":"10033_CR75","doi-asserted-by":"publisher","unstructured":"Hofbauer, D., Mougiakakos, D., Broggini, L., Zaiss, M., B\u00fcttner-Herold, M., Bach, C., \u2026 Bruns, H. (2021). \u03b22-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression. Immunity. https:\/\/doi.org\/10.1016\/j.immuni.2021.07.002","DOI":"10.1016\/j.immuni.2021.07.002"},{"key":"10033_CR76","doi-asserted-by":"publisher","unstructured":"Li, Y., Li, N., Yan, Z., Li, H., Chen, L., Zhang, Z., \u2026 Li, Z. (2016). Dysregulation of the NLRP3 inflammasome complex and related cytokines in patients with multiple myeloma. Hematology , 21(3), 144\u2013151. https:\/\/doi.org\/10.1179\/1607845415Y.0000000029","DOI":"10.1179\/1607845415Y.0000000029"},{"key":"10033_CR77","doi-asserted-by":"publisher","unstructured":"Zhao, X., Hua, M., Yan, S., Yu, J., Han, F., Zhong, C., \u2026 Ma, D. (2018). The genetic polymorphisms of NLRP3 inflammasome associated with T helper cells in patients with multiple myeloma. Journal of immunology research, 2018, 7569809. https:\/\/doi.org\/10.1155\/2018\/7569809","DOI":"10.1155\/2018\/7569809"},{"issue":"1","key":"10033_CR78","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mi.2007.6","volume":"2008","author":"AJ Macpherson","year":"2007","unstructured":"Macpherson, A. J., McCoy, K. D., Johansen, F. E., & Brandtzaeg, P. (2007). The immune geography of IgA induction and function. Mucosal Immunology, 2008(1), 11\u201322. PMID: 19079156.","journal-title":"Mucosal Immunology"},{"key":"10033_CR79","doi-asserted-by":"crossref","unstructured":"Chiba, T., Honjo, T., & Fagarasan, S. (2004). Aberrant expansion of segmented filamentous bacteria in IgA-deficient gut. Proceedings of the. Retrieved from https:\/\/www.pnas.org\/content\/101\/7\/1981.short. Accessed 3 Jan 2022","DOI":"10.1073\/pnas.0307317101"},{"issue":"9","key":"10033_CR80","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/intimm\/dxu059","volume":"26","author":"K Suzuki","year":"2014","unstructured":"Suzuki, K., & Nakajima, A. (2014). New aspects of IgA synthesis in the gut. International immunology, 26(9), 489\u2013494. https:\/\/doi.org\/10.1093\/intimm\/dxu059","journal-title":"International immunology"},{"key":"10033_CR81","unstructured":"SEER, National Cancer Institute. (n.d.). SEER cancer stat facts: Myeloma. National Cancer Institute. Bethesda, MD. SEER Cancer Stat Facts: Myeloma. Retrieved September 19, 2020, from https:\/\/seer.cancer.gov\/statfacts\/html\/mulmy.html. Accessed 3 Jan 2022"},{"key":"10033_CR82","doi-asserted-by":"publisher","unstructured":"Bolli, N., Maura, F., Minvielle, S., Gloznik, D., Szalat, R., Fullam, A., \u2026 Munshi, N. (2018). Genomic patterns of progression in smoldering multiple myeloma. Nature communications, 9(1), 3363. https:\/\/doi.org\/10.1038\/s41467-018-05058-y","DOI":"10.1038\/s41467-018-05058-y"},{"key":"10033_CR83","doi-asserted-by":"publisher","unstructured":"Oben, B., Froyen, G., Maclachlan, K. H., Leongamornlert, D., Abascal, F., Zheng-Lin, B., \u2026 Maura, F. (2021). Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities. Nature communications, 12(1), 1861. https:\/\/doi.org\/10.1038\/s41467-021-22140-0","DOI":"10.1038\/s41467-021-22140-0"},{"key":"10033_CR84","doi-asserted-by":"publisher","unstructured":"Maura, F., Bolli, N., Angelopoulos, N., Dawson, K. J., Leongamornlert, D., Martincorena, I., \u2026 Campbell, P. J. (2019). Genomic landscape and chronological reconstruction of driver events in multiple myeloma. Nature communications, 10(1), 3835. https:\/\/doi.org\/10.1038\/s41467-019-11680-1","DOI":"10.1038\/s41467-019-11680-1"},{"issue":"9","key":"10033_CR85","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","volume":"15","author":"L Ferrucci","year":"2018","unstructured":"Ferrucci, L., & Fabbri, E. (2018). Inflammageing: Chronic inflammation in ageing, cardiovascular disease, and frailty. Nature reviews. Cardiology, 15(9), 505\u2013522. https:\/\/doi.org\/10.1038\/s41569-018-0064-2","journal-title":"Nature reviews. Cardiology"},{"key":"10033_CR86","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12979-017-0112-5","volume":"15","author":"GC Leonardi","year":"2018","unstructured":"Leonardi, G. C., Accardi, G., Monastero, R., Nicoletti, F., & Libra, M. (2018). Ageing: From inflammation to cancer. Immunity & ageing: I & A, 15, 1. https:\/\/doi.org\/10.1186\/s12979-017-0112-5","journal-title":"Immunity & ageing: I & A"},{"issue":"6","key":"10033_CR87","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","volume":"39","author":"C Garlanda","year":"2013","unstructured":"Garlanda, C., Dinarello, C. A., & Mantovani, A. (2013). The interleukin-1 family: Back to the future. Immunity, 39(6), 1003\u20131018. https:\/\/doi.org\/10.1016\/j.immuni.2013.11.010","journal-title":"Immunity"},{"key":"10033_CR88","doi-asserted-by":"publisher","unstructured":"Kovtonyuk, L. V., Caiado, F., Garcia-Martin, S., Manz, E.-M., Helbling, P., Takizawa, H., \u2026 Manz, M. G. (2022). IL-1 mediates microbiome-induced inflammaging of hematopoietic stem cells in mice. Blood, 139(1), 44\u201358. https:\/\/doi.org\/10.1182\/blood.2021011570","DOI":"10.1182\/blood.2021011570"},{"key":"10033_CR89","doi-asserted-by":"publisher","unstructured":"Jaiswal, S., & Ebert, B. L. (2019). Clonal hematopoiesis in human aging and disease. Science, 366(6465). https:\/\/doi.org\/10.1126\/science.aan4673","DOI":"10.1126\/science.aan4673"},{"issue":"3","key":"10033_CR90","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058504","volume":"8","author":"MM Zheng","year":"2013","unstructured":"Zheng, M. M., Zhang, Z., Bemis, K., Belch, A. R., Pilarski, L. M., Shively, J. E., & Kirshner, J. (2013). The systemic cytokine environment is permanently altered in multiple myeloma. PLoS ONE, 8(3), e58504. https:\/\/doi.org\/10.1371\/journal.pone.0058504","journal-title":"PLoS ONE"},{"key":"10033_CR91","doi-asserted-by":"publisher","unstructured":"Guillerey, C., Nakamura, K., Vuckovic, S., Hill, G. R., & Smyth, M. J. (2016). Immune responses in multiple myeloma: Role of the natural immune surveillance and potential of immunotherapies. Cellular and molecular life sciences: CMLS, 73(8), 1569\u20131589. https:\/\/doi.org\/10.1007\/s00018-016-2135-z. Accessed 3 Jan 2022","DOI":"10.1007\/s00018-016-2135-z"},{"key":"10033_CR92","doi-asserted-by":"publisher","first-page":"1852517","DOI":"10.1155\/2017\/1852517","volume":"2017","author":"C Musolino","year":"2017","unstructured":"Musolino, C., Allegra, A., Innao, V., Allegra, A. G., Pioggia, G., & Gangemi, S. (2017). Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: The role of cytokines in multiple myeloma. Mediators of inflammation, 2017, 1852517. https:\/\/doi.org\/10.1155\/2017\/1852517","journal-title":"Mediators of inflammation"},{"key":"10033_CR93","doi-asserted-by":"publisher","unstructured":"Chen, L., Sun, M., Wu, W., Yang, W., Huang, X., Xiao, Y., \u2026 Cong, Y. (2019). Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells\u2019 differentiation and function in induction of colitis. Inflammatory bowel diseases, 25(9), 1450\u20131461. https:\/\/doi.org\/10.1093\/ibd\/izz046","DOI":"10.1093\/ibd\/izz046"},{"key":"10033_CR94","doi-asserted-by":"publisher","unstructured":"Voorhees, P. M., Manges, R. F., Sonneveld, P., Jagannath, S., Somlo, G., Krishnan, A., \u2026 Thomas, S. K. (2013). A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma. British journal of haematology, 161(3), 357\u2013366. https:\/\/doi.org\/10.1111\/bjh.12266","DOI":"10.1111\/bjh.12266"},{"key":"10033_CR95","doi-asserted-by":"crossref","unstructured":"San-Miguel, J., Blad\u00e9, J., Shpilberg, O., Grosicki, S., Maloisel, F., Min, C.-K., \u2026 Others. (2014). Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti--IL-6) in multiple myeloma. Blood, The Journal of the American Society of Hematology, 123(26), 4136\u20134142. Retrieved from https:\/\/ashpublications.org\/blood\/article-abstract\/123\/26\/4136\/32785","DOI":"10.1182\/blood-2013-12-546374"},{"key":"10033_CR96","doi-asserted-by":"publisher","unstructured":"Kurzrock, R., Voorhees, P. M., Casper, C., Furman, R. R., Fayad, L., Lonial, S., \u2026 van Rhee, F. (2013). A phase I, open-label study of siltuximab, an anti-IL-6 monoclonal antibody, in patients with B-cell non-Hodgkin lymphoma, multiple myeloma, or Castleman disease. Clinical cancer research: an official journal of the American Association for Cancer Research, 19(13), 3659\u20133670. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-3349","DOI":"10.1158\/1078-0432.CCR-12-3349"},{"issue":"6","key":"10033_CR97","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/ajh.24352","volume":"91","author":"JA Lust","year":"2016","unstructured":"Lust, J. A., Lacy, M. Q., Zeldenrust, S. R., Witzig, T. E., Moon-Tasson, L. L., Dinarello, C. A., & Donovan, K. A. (2016). Reduction in C-reactive protein indicates successful targeting of the IL-1\/IL-6 axis resulting in improved survival in early stage multiple myeloma. American journal of hematology, 91(6), 571\u2013574. https:\/\/doi.org\/10.1002\/ajh.24352","journal-title":"American journal of hematology"},{"key":"10033_CR98","doi-asserted-by":"publisher","unstructured":"Pianko, M. J., Devlin, S. M., Littmann, E. R., Chansakul, A., Mastey, D., Salcedo, M., \u2026 Lesokhin, A. M. (2019). Minimal residual disease negativity in multiple myeloma is associated with intestinal microbiota composition. Blood advances, 3(13), 2040\u20132044. https:\/\/doi.org\/10.1182\/bloodadvances.2019032276","DOI":"10.1182\/bloodadvances.2019032276"},{"key":"10033_CR99","doi-asserted-by":"publisher","unstructured":"Shah, U., Derkach, A., Adintori, P., Cross, J., Maclachlan, K., Mailankody, S., \u2026 Lesokhin, A. (2021). P-042: Sustained minimal residual disease negativity in Multiple Myeloma is impacted positively by stool butyrate and healthier plant forward diets. Clinical lymphoma, myeloma & leukemia, 21, S61. https:\/\/doi.org\/10.1016\/s2152-2650(21)02176-5","DOI":"10.1016\/s2152-2650(21)02176-5"},{"key":"10033_CR100","doi-asserted-by":"publisher","unstructured":"Jian, X., Zhu, Y., Ouyang, J., Wang, Y., Lei, Q., Xia, J., \u2026 Zhou, W. (2020). Alterations of gut microbiome accelerate multiple myeloma progression by increasing the relative abundances of nitrogen-recycling bacteria. Microbiome, 8(1), 74. https:\/\/doi.org\/10.1186\/s40168-020-00854-5","DOI":"10.1186\/s40168-020-00854-5"},{"key":"10033_CR101","doi-asserted-by":"publisher","unstructured":"Drayson, M. T., Bowcock, S., Planche, T., Iqbal, G., Pratt, G., Yong, K., \u2026 TEAMM Trial Management Group and Trial Investigators. (2019). Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial. The lancet oncology, 20(12), 1760\u20131772. https:\/\/doi.org\/10.1016\/S1470-2045(19)30506-6","DOI":"10.1016\/S1470-2045(19)30506-6"},{"key":"10033_CR102","doi-asserted-by":"publisher","unstructured":"Albrich, W. C., & Boggian, K. (2020, February). Levofloxacin prophylaxis in patients with myeloma. The lancet oncology. https:\/\/doi.org\/10.1016\/S1470-2045(20)30008-5","DOI":"10.1016\/S1470-2045(20)30008-5"},{"key":"10033_CR103","doi-asserted-by":"publisher","unstructured":"Teh, B. W., Harrison, S. J., Worth, L. J., Thursky, K. A., & Slavin, M. A. (2020, February). Levofloxacin prophylaxis in patients with myeloma. The lancet oncology. https:\/\/doi.org\/10.1016\/S1470-2045(19)30824-1","DOI":"10.1016\/S1470-2045(19)30824-1"},{"key":"10033_CR104","doi-asserted-by":"publisher","unstructured":"Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillere, R., Hannani, D., \u2026 Zitvogel, L. (2013). The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science, 342(6161), 971\u2013976. https:\/\/doi.org\/10.1126\/science.1240537","DOI":"10.1126\/science.1240537"},{"key":"10033_CR105","doi-asserted-by":"publisher","unstructured":"Matson, V., Fessler, J., Bao, R., Chongsuwat, T., Zha, Y., Alegre, M.-L., \u2026 Gajewski, T. F. (2018). The commensal microbiome is associated with anti\u2013PD-1 efficacy in metastatic melanoma patients. Science. https:\/\/doi.org\/10.1126\/science.aao3290","DOI":"10.1126\/science.aao3290"},{"key":"10033_CR106","doi-asserted-by":"publisher","unstructured":"El Jurdi, N., Filali-Mouhim, A., Salem, I., Retuerto, M., Dambrosio, N. M., Baer, L., \u2026 de Lima, M. (2019). Gastrointestinal microbiome and mycobiome changes during autologous transplantation for multiple myeloma: Results of a prospective pilot study. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 25(8), 1511\u20131519. https:\/\/doi.org\/10.1016\/j.bbmt.2019.04.007","DOI":"10.1016\/j.bbmt.2019.04.007"},{"key":"10033_CR107","doi-asserted-by":"publisher","unstructured":"Holler, E., Butzhammer, P., Schmid, K., Hundsrucker, C., Koestler, J., Peter, K., \u2026 Oefner, P. J. (2014). Metagenomic analysis of the stool microbiome in patients receiving allogeneic stem cell transplantation: Loss of diversity is associated with use of systemic antibiotics and more pronounced in gastrointestinal graft-versus-host disease. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 20(5), 640\u2013645. https:\/\/doi.org\/10.1016\/j.bbmt.2014.01.030","DOI":"10.1016\/j.bbmt.2014.01.030"},{"key":"10033_CR108","doi-asserted-by":"publisher","unstructured":"Taur, Y., Xavier, J. B., Lipuma, L., Ubeda, C., Goldberg, J., Gobourne, A., \u2026 Pamer, E. G. (2012). Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 55(7), 905\u2013914. https:\/\/doi.org\/10.1093\/cid\/cis580","DOI":"10.1093\/cid\/cis580"},{"key":"10033_CR109","doi-asserted-by":"publisher","unstructured":"Golob, J. L., Pergam, S. A., Srinivasan, S., Fiedler, T. L., Liu, C., Garcia, K., \u2026 Fredricks, D. N. (2017). Stool microbiota at neutrophil recovery is predictive for severe acute graft vs host disease after hematopoietic cell transplantation. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 65(12), 1984\u20131991. https:\/\/doi.org\/10.1093\/cid\/cix699","DOI":"10.1093\/cid\/cix699"},{"key":"10033_CR110","doi-asserted-by":"publisher","unstructured":"Taur, Y., Jenq, R. R., Perales, M. A., Littmann, E. R., Morjaria, S., Ling, L., \u2026 Pamer, E. G. (2014). The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation. Blood, 124(7), 1174\u20131182. https:\/\/doi.org\/10.1182\/blood-2014-02-554725","DOI":"10.1182\/blood-2014-02-554725"},{"key":"10033_CR111","doi-asserted-by":"publisher","unstructured":"Jenq, R. R., Taur, Y., Devlin, S. M., Ponce, D. M., Goldberg, J. D., Ahr, K. F., \u2026 van den Brink, M. R. (2015). Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 21(8), 1373\u20131383. https:\/\/doi.org\/10.1016\/j.bbmt.2015.04.016","DOI":"10.1016\/j.bbmt.2015.04.016"},{"key":"10033_CR112","doi-asserted-by":"publisher","unstructured":"Shono, Y., Docampo, M. D., Peled, J. U., Perobelli, S. M., Velardi, E., Tsai, J. J., \u2026 Jenq, R. R. (2016). Increased GVHD-related mortality with broad-spectrum antibiotic use after allogeneic hematopoietic stem cell transplantation in human patients and mice. Science translational medicine, 8(339), 339ra71. https:\/\/doi.org\/10.1126\/scitranslmed.aaf2311","DOI":"10.1126\/scitranslmed.aaf2311"},{"key":"10033_CR113","doi-asserted-by":"publisher","unstructured":"Hidaka, D., Hayase, E., Shiratori, S., Hasegawa, Y., Ishio, T., Tateno, T., \u2026 Teshima, T. (2018). The association between the incidence of intestinal graft-vs-host disease and antibiotic use after allogeneic hematopoietic stem cell transplantation. Clinical transplantation, 32(9), e13361. https:\/\/doi.org\/10.1111\/ctr.13361","DOI":"10.1111\/ctr.13361"},{"key":"10033_CR114","doi-asserted-by":"publisher","unstructured":"Peled, J. U., Devlin, S. M., Staffas, A., Lumish, M., Khanin, R., Littmann, E. R., \u2026 van den Brink, M. R. M. (2017). Intestinal microbiota and relapse after hematopoietic-cell transplantation. Journal of clinical oncology: official journal of the American Society of Clinical Oncology, 35(15), 1650\u20131659. https:\/\/doi.org\/10.1200\/JCO.2016.70.3348","DOI":"10.1200\/JCO.2016.70.3348"},{"key":"10033_CR115","doi-asserted-by":"publisher","unstructured":"Ubeda, C., Taur, Y., Jenq, R. R., Equinda, M. J., Son, T., Samstein, M., \u2026 Pamer, E. G. (2010). Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. The Journal of clinical investigation, 120(12), 4332\u20134341. https:\/\/doi.org\/10.1172\/JCI43918","DOI":"10.1172\/JCI43918"},{"key":"10033_CR116","doi-asserted-by":"publisher","unstructured":"Haak, B. W., Littmann, E. R., Chaubard, J.-L., Pickard, A. J., Fontana, E., Adhi, F., \u2026 Taur, Y. (2018). Impact of gut colonization with butyrate-producing microbiota on respiratory viral infection following allo-HCT. Blood, 131(26), 2978\u20132986. https:\/\/doi.org\/10.1182\/blood-2018-01-828996","DOI":"10.1182\/blood-2018-01-828996"},{"key":"10033_CR117","doi-asserted-by":"publisher","unstructured":"Harris, B., Morjaria, S. M., Littmann, E. R., Geyer, A. I., Stover, D. E., Barker, J. N., \u2026 Pamer, E. G. (2016). Gut microbiota predict pulmonary infiltrates after allogeneic hematopoietic cell transplantation. American journal of respiratory and critical care medicine, 194(4), 450\u2013463. https:\/\/doi.org\/10.1164\/rccm.201507-1491OC","DOI":"10.1164\/rccm.201507-1491OC"},{"key":"10033_CR118","doi-asserted-by":"publisher","unstructured":"Peled, J. U., Gomes, A. L. C., Devlin, S. M., Littmann, E. R., Taur, Y., Sung, A. D., \u2026 van den Brink, M. R. M. (2020). Microbiota as predictor of mortality in allogeneic hematopoietic-cell transplantation. The New England journal of medicine, 382(9), 822\u2013834. https:\/\/doi.org\/10.1056\/NEJMoa1900623","DOI":"10.1056\/NEJMoa1900623"},{"issue":"2","key":"10033_CR119","doi-asserted-by":"publisher","first-page":"102","DOI":"10.5045\/br.2016.51.2.102","volume":"51","author":"I Stoma","year":"2016","unstructured":"Stoma, I., Karpov, I., Milanovich, N., Uss, A., & Iskrov, I. (2016). Risk factors for mortality in patients with bloodstream infections during the pre-engraftment period after hematopoietic stem cell transplantation. Blood research, 51(2), 102\u2013106. https:\/\/doi.org\/10.5045\/br.2016.51.2.102","journal-title":"Blood research"},{"key":"10033_CR120","doi-asserted-by":"publisher","unstructured":"Trecarichi, E. M., Pagano, L., Candoni, A., Pastore, D., Cattaneo, C., Fanci, R., \u2026 HeMABIS Registry\u2014SEIFEM Group, Italy. (2015). Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: An Italian multicentre prospective survey. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 21(4), 337\u2013343. https:\/\/doi.org\/10.1016\/j.cmi.2014.11.022","DOI":"10.1016\/j.cmi.2014.11.022"},{"key":"10033_CR121","doi-asserted-by":"crossref","unstructured":"Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Ya\u0148ez San Segundo, L., \u2026 Others. (2017). Antimicrobial resistance in Gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: Intercontinental prospective study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 65(11), 1819\u20131828. Retrieved from https:\/\/academic.oup.com\/cid\/article-abstract\/65\/11\/1819\/4036247. Accessed 3 Jan 2022","DOI":"10.1093\/cid\/cix646"},{"key":"10033_CR122","doi-asserted-by":"publisher","unstructured":"Storb, R., Prentice, R. L., Buckner, C. D., Clift, R. A., Appelbaum, F., Deeg, J., \u2026 Thomas, E. D. (1983). Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. The New England journal of medicine, 308(6), 302\u2013307. https:\/\/doi.org\/10.1056\/NEJM198302103080602","DOI":"10.1056\/NEJM198302103080602"},{"key":"10033_CR123","doi-asserted-by":"publisher","unstructured":"Cruciani, M., Rampazzo, R., Malena, M., Lazzarini, L., Todeschini, G., Messori, A., & Concia, E. (1996). Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: A meta-analysis. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 23(4), 795\u2013805. https:\/\/doi.org\/10.1093\/clinids\/23.4.795","DOI":"10.1093\/clinids\/23.4.795"},{"issue":"3","key":"10033_CR124","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1200\/JCO.1998.16.3.1179","volume":"16","author":"EA Engels","year":"1998","unstructured":"Engels, E. A., Lau, J., & Barza, M. (1998). Efficacy of quinolone prophylaxis in neutropenic cancer patients: A meta-analysis. Journal of clinical oncology: Official journal of the American Society of Clinical Oncology, 16(3), 1179\u20131187. https:\/\/doi.org\/10.1200\/JCO.1998.16.3.1179","journal-title":"Journal of clinical oncology: Official journal of the American Society of Clinical Oncology"},{"key":"10033_CR125","doi-asserted-by":"crossref","unstructured":"Nagatomo, A., Watanabe, K., Kunikane, H., Okamoto, H., & Kunitoh, H. (1998). A randomized controled trial of sulfamethoxazole\/trimethoprim plus norfloxacin versus sulfamethoxazole\/trimethoprim alone for the prophylaxis of bacterial infection during chemotherapy for lung cancer. Lung cancer , 19(2), 121\u2013125. Retrieved from https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0169500297000871?casa_token=rueotu1UrxQAAAAA:GFf46QwLznRrllvqNVW7dqcS0VnozNfQ2jHNdJsIj9oTJp7SCK4hBG7QCAOzcVcG79gIzxoy. Accessed 3 Jan 2022","DOI":"10.1016\/S0169-5002(97)00087-1"},{"key":"10033_CR126","doi-asserted-by":"publisher","unstructured":"Bucaneve, G., Micozzi, A., Menichetti, F., Martino, P., Stella Dionisi, M., Martinelli, G., \u2026 Del Favero, A. (2005). Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/nejmoa044097","DOI":"10.1056\/nejmoa044097"},{"key":"10033_CR127","doi-asserted-by":"publisher","unstructured":"Cullen, M., Steven, N., Billingham, L., Gaunt, C., Hastings, M., Simmonds, P., \u2026 Stanley, A. (2005). Antibacterial prophylaxis after chemotherapy for solid tumors and lymphomas. New England Journal of Medicine. https:\/\/doi.org\/10.1056\/nejmoa050078","DOI":"10.1056\/nejmoa050078"},{"issue":"12 Pt 1","key":"10033_CR128","doi-asserted-by":"publisher","first-page":"979","DOI":"10.7326\/0003-4819-142-12_part_1-200506210-00008","volume":"142","author":"A Gafter-Gvili","year":"2005","unstructured":"Gafter-Gvili, A., Fraser, A., Paul, M., & Leibovici, L. (2005). Meta-analysis: Antibiotic prophylaxis reduces mortality in neutropenic patients. Annals of Internal Medicine, 142(12 Pt 1), 979\u2013995. https:\/\/doi.org\/10.7326\/0003-4819-142-12_part_1-200506210-00008","journal-title":"Annals of Internal Medicine"},{"key":"10033_CR129","doi-asserted-by":"publisher","unstructured":"Kimura, S.-I., Akahoshi, Y., Nakano, H., Ugai, T., Wada, H., Yamasaki, R., \u2026 Kanda, Y. (2014). Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. The Journal of infection, 69(1), 13\u201325. https:\/\/doi.org\/10.1016\/j.jinf.2014.02.013","DOI":"10.1016\/j.jinf.2014.02.013"},{"issue":"3","key":"10033_CR130","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.chom.2014.02.006","volume":"15","author":"A Khosravi","year":"2014","unstructured":"Khosravi, A., Y\u00e1\u00f1ez, A., Price, J. G., Chow, A., Merad, M., Goodridge, H. S., & Mazmanian, S. K. (2014). Gut microbiota promote hematopoiesis to control bacterial infection. Cell host & microbe, 15(3), 374\u2013381. https:\/\/doi.org\/10.1016\/j.chom.2014.02.006","journal-title":"Cell host & microbe"},{"issue":"6","key":"10033_CR131","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1182\/blood-2016-03-708594","volume":"129","author":"KS Josefsdottir","year":"2017","unstructured":"Josefsdottir, K. S., Baldridge, M. T., Kadmon, C. S., & King, K. Y. (2017). Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota. Blood, 129(6), 729\u2013739. https:\/\/doi.org\/10.1182\/blood-2016-03-708594","journal-title":"Blood"},{"issue":"8","key":"10033_CR132","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1093\/cid\/cir1035","volume":"54","author":"CD Alonso","year":"2012","unstructured":"Alonso, C. D., Treadway, S. B., Hanna, D. B., Huff, C. A., Neofytos, D., Carroll, K. C., & Marr, K. A. (2012). Epidemiology and outcomes of Clostridium difficile infections in hematopoietic stem cell transplant recipients. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America, 54(8), 1053\u20131063. https:\/\/doi.org\/10.1093\/cid\/cir1035","journal-title":"Clinical infectious diseases: An official publication of the Infectious Diseases Society of America"},{"issue":"6","key":"10033_CR133","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1182\/blood-2018-02-832519","volume":"132","author":"H Yan","year":"2018","unstructured":"Yan, H., Baldridge, M. T., & King, K. Y. (2018). Hematopoiesis and the bacterial microbiome. Blood, 132(6), 559\u2013564. https:\/\/doi.org\/10.1182\/blood-2018-02-832519","journal-title":"Blood"},{"key":"10033_CR134","doi-asserted-by":"publisher","unstructured":"Staffas, A., Burgos da Silva, M., Slingerland, A. E., Lazrak, A., Bare, C. J., Holman, C. D., \u2026 van den Brink, M. R. M. (2018). Nutritional support from the intestinal microbiota improves hematopoietic reconstitution after bone marrow transplantation in mice. Cell host & microbe, 23(4), 447-457.e4. https:\/\/doi.org\/10.1016\/j.chom.2018.03.002","DOI":"10.1016\/j.chom.2018.03.002"},{"issue":"11","key":"10033_CR135","doi-asserted-by":"publisher","first-page":"e4627","DOI":"10.1093\/cid\/ciaa068","volume":"73","author":"I Stoma","year":"2021","unstructured":"Stoma, I., Littmann, E. R., Peled, J. U., Giralt, S., van den Brink, M. R. M., Pamer, E. G., & Taur, Y. (2021). Compositional flux within the intestinal microbiota and risk for bloodstream infection with gram-negative bacteria. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America, 73(11), e4627\u2013e4635. https:\/\/doi.org\/10.1093\/cid\/ciaa068","journal-title":"Clinical infectious diseases: An official publication of the Infectious Diseases Society of America"},{"key":"10033_CR136","doi-asserted-by":"publisher","unstructured":"Donskey, C. J., Chowdhry, T. K., Hecker, M. T., Hoyen, C. K., Hanrahan, J. A., Hujer, A. M., \u2026 Rice, L. B. (2000). Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. The New England journal of medicine, 343(26), 1925\u20131932. https:\/\/doi.org\/10.1056\/NEJM200012283432604","DOI":"10.1056\/NEJM200012283432604"},{"issue":"12","key":"10033_CR137","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1038\/s41591-018-0202-8","volume":"24","author":"FB Tamburini","year":"2018","unstructured":"Tamburini, F. B., Andermann, T. M., Tkachenko, E., Senchyna, F., Banaei, N., & Bhatt, A. S. (2018). Precision identification of diverse bloodstream pathogens in the gut microbiome. Nature medicine, 24(12), 1809\u20131814. https:\/\/doi.org\/10.1038\/s41591-018-0202-8","journal-title":"Nature medicine"},{"key":"10033_CR138","doi-asserted-by":"publisher","unstructured":"Caballero, S., Kim, S., Carter, R. A., Leiner, I. M., Su\u0161ac, B., Miller, L., \u2026 Pamer, E. G. (2017). Cooperating commensals restore colonization resistance to vancomycin-resistant Enterococcus faecium. Cell host & microbe, 21(5), 592-602.e4. https:\/\/doi.org\/10.1016\/j.chom.2017.04.002","DOI":"10.1016\/j.chom.2017.04.002"},{"key":"10033_CR139","unstructured":"Gilmore, M. S., Clewell, D. B., Ike, Y., & Shankar, N. (Eds.). (2014). Enterococci: From commensals to leading causes of drug resistant infection. Boston: Massachusetts Eye and Ear Infirmary. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24649510. Accessed 3 Jan 2022"},{"key":"10033_CR140","doi-asserted-by":"publisher","unstructured":"Buffie, C. G., Bucci, V., Stein, R. R., McKenney, P. T., Ling, L., Gobourne, A., \u2026 Pamer, E. G. (2015). Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile. Nature, 517(7533), 205\u2013208. https:\/\/doi.org\/10.1038\/nature13828","DOI":"10.1038\/nature13828"},{"key":"10033_CR141","doi-asserted-by":"publisher","unstructured":"Miltiadous, O., Waters, N. R., Andrlova, H., Dai, A., Nguyen, C. L., Burgos da Silva, M., \u2026 van den Brink, M. R. M. (2022). Early intestinal microbial features are associated with CD4 T cell recovery after allogeneic hematopoietic transplant. Blood. https:\/\/doi.org\/10.1182\/blood.2021014255","DOI":"10.1182\/blood.2021014255"},{"key":"10033_CR142","unstructured":"Centers for Disease Control and Prevention, Infectious Disease Society of America, & American Society of Blood and Marrow Transplantation. (2000). Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports \/ Centers for Disease Control, 49(RR-10), 1\u2013125, CE1\u20137. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11718124. Accessed 3 Jan 2022"},{"key":"10033_CR143","doi-asserted-by":"publisher","unstructured":"Maakaron, J. E., Liscynesky, C., Boghdadly, Z. E., Huang, Y., Agyeman, A., Brammer, J., \u2026 Jaglowski, S. M. (2020). Fluoroquinolone prophylaxis in autologous stem cell transplantation: Worthy of a second look. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 26(8), e198\u2013e201. https:\/\/doi.org\/10.1016\/j.bbmt.2020.03.027","DOI":"10.1016\/j.bbmt.2020.03.027"},{"issue":"11","key":"10033_CR144","doi-asserted-by":"publisher","first-page":"E348","DOI":"10.1002\/ajh.25236","volume":"93","author":"A Rashidi","year":"2018","unstructured":"Rashidi, A., Wangjam, T., Bhatt, A. S., Weisdorf, D. J., Holtan, S. G., & Investigators, B. M. T. C. T. N. (2018). Antibiotic practice patterns in hematopoietic cell transplantation: A survey of blood and marrow transplant clinical trials network centers. American journal of hematology, 93(11), E348\u2013E350. https:\/\/doi.org\/10.1002\/ajh.25236","journal-title":"American journal of hematology"},{"key":"10033_CR145","doi-asserted-by":"publisher","unstructured":"Arai, S., Arora, M., Wang, T., Spellman, S. R., He, W., Couriel, D. R., \u2026 Pavletic, S. Z. (2015). Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: A report from the center for international blood and marrow transplant research. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 21(2), 266\u2013274. https:\/\/doi.org\/10.1016\/j.bbmt.2014.10.021","DOI":"10.1016\/j.bbmt.2014.10.021"},{"key":"10033_CR146","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1750-1172-2-35","volume":"2","author":"DA Jacobsohn","year":"2007","unstructured":"Jacobsohn, D. A., & Vogelsang, G. B. (2007). Acute graft versus host disease. Orphanet journal of rare diseases, 2, 35. https:\/\/doi.org\/10.1186\/1750-1172-2-35","journal-title":"Orphanet journal of rare diseases"},{"key":"10033_CR147","doi-asserted-by":"publisher","unstructured":"Storb, R., Gyurkocza, B., Storer, B. E., Maloney, D. G., Sorror, M. L., Mielcarek, M., \u2026 Sandmaier, B. M. (2013). Allogeneic hematopoietic cell transplantation following minimal intensity conditioning: Predicting acute graft-versus-host disease and graft-versus-tumor effects. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 19(5), 792\u2013798. https:\/\/doi.org\/10.1016\/j.bbmt.2013.02.006","DOI":"10.1016\/j.bbmt.2013.02.006"},{"issue":"4","key":"10033_CR148","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.trsl.2007.06.003","volume":"150","author":"Y Sun","year":"2007","unstructured":"Sun, Y., Tawara, I., Toubai, T., & Reddy, P. (2007). Pathophysiology of acute graft-versus-host disease: Recent advances. Translational research: The journal of laboratory and clinical medicine, 150(4), 197\u2013214. https:\/\/doi.org\/10.1016\/j.trsl.2007.06.003","journal-title":"Translational research: The journal of laboratory and clinical medicine"},{"key":"10033_CR149","doi-asserted-by":"publisher","unstructured":"Stein-Thoeringer, C. K., Nichols, K. B., Lazrak, A., Docampo, M. D., Slingerland, A. E., Slingerland, J. B., \u2026 van den Brink, M. R. M. (2019). Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science (New York, N.Y.), 366(6469), 1143\u20131149. https:\/\/doi.org\/10.1126\/science.aax3760","DOI":"10.1126\/science.aax3760"},{"key":"10033_CR150","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/0024-3205(65)90011-1","volume":"4","author":"MS Connell","year":"1965","unstructured":"Connell, M. S., & Wilson, R. (1965). The treatment of x-irradiated germfree CFW and C3H mice with isologous and homologous bone marrow. Life sciences, 4, 721\u2013729. https:\/\/doi.org\/10.1016\/0024-3205(65)90011-1","journal-title":"Life sciences"},{"key":"10033_CR151","doi-asserted-by":"crossref","unstructured":"Jones, J. M., Wilson, R., & Bealmear, P. M. (1971). Mortality and gross pathology of secondary disease in germfree mouse radiation chimeras. Radiation research, 45(3), 577\u2013588. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/4396814. Accessed 3 Jan 2022","DOI":"10.2307\/3573066"},{"key":"10033_CR152","unstructured":"Bealmear, P. M., Mirand, E. A., & Holtermann, O. A. (1983). Modification of graft-vs-host disease following bone marrow transplantation in germfree mice. Progress in clinical and biological research, 132C, 409\u2013421. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/6227014. Accessed 3 Jan 2022"},{"key":"10033_CR153","unstructured":"Bauer, H., Horowitz, R. E., Levenson, S. M., & Popper, H. (1963). The response of the lymphatic tissue to the microbial flora. Studies on germfree mice. The American journal of pathology, 42, 471\u2013483. Retrieved from https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/13966929. Accessed 3 Jan 2022"},{"issue":"6086","key":"10033_CR154","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper, L. V., Littman, D. R., & Macpherson, A. J. (2012). Interactions between the microbiota and the immune system. Science, 336(6086), 1268\u20131273. https:\/\/doi.org\/10.1126\/science.1223490","journal-title":"Science"},{"issue":"5","key":"10033_CR155","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/nri2515","volume":"9","author":"JL Round","year":"2009","unstructured":"Round, J. L., & Mazmanian, S. K. (2009). The gut microbiota shapes intestinal immune responses during health and disease. Nature reviews. Immunology, 9(5), 313\u2013323. https:\/\/doi.org\/10.1038\/nri2515","journal-title":"Nature reviews. Immunology"},{"issue":"5","key":"10033_CR156","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1172\/JCI125797","volume":"129","author":"DN Fredricks","year":"2019","unstructured":"Fredricks, D. N. (2019). The gut microbiota and graft-versus-host disease. The Journal of clinical investigation, 129(5), 1808\u20131817. https:\/\/doi.org\/10.1172\/JCI125797","journal-title":"The Journal of clinical investigation"},{"issue":"11","key":"10033_CR157","doi-asserted-by":"publisher","first-page":"4365","DOI":"10.1182\/blood-2003-11-3769","volume":"103","author":"A Gerbitz","year":"2004","unstructured":"Gerbitz, A., Schultz, M., Wilke, A., Linde, H.-J., Sch\u00f6lmerich, J., Andreesen, R., & Holler, E. (2004). Probiotic effects on experimental graft-versus-host disease: Let them eat yogurt. Blood, 103(11), 4365\u20134367. https:\/\/doi.org\/10.1182\/blood-2003-11-3769","journal-title":"Blood"},{"key":"10033_CR158","doi-asserted-by":"publisher","unstructured":"Weber, D., Jenq, R. R., Peled, J. U., Taur, Y., Hiergeist, A., Koestler, J., \u2026 Holler, E. (2017). Microbiota disruption induced by early use of broad-spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 23(5), 845\u2013852. https:\/\/doi.org\/10.1016\/j.bbmt.2017.02.006","DOI":"10.1016\/j.bbmt.2017.02.006"},{"key":"10033_CR159","doi-asserted-by":"publisher","unstructured":"Weber, D., Oefner, P. J., Dettmer, K., Hiergeist, A., Koestler, J., Gessner, A., \u2026 Holler, E. (2016). Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation. Bone marrow transplantation, 51(8), 1087\u20131092. https:\/\/doi.org\/10.1038\/bmt.2016.66","DOI":"10.1038\/bmt.2016.66"},{"key":"10033_CR160","doi-asserted-by":"publisher","unstructured":"Romick-Rosendale, L. E., Haslam, D. B., Lane, A., Denson, L., Lake, K., Wilkey, A., \u2026 Davies, S. M. (2018). Antibiotic exposure and reduced short chain fatty acid production after hematopoietic stem cell transplant. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation, 24(12), 2418\u20132424. https:\/\/doi.org\/10.1016\/j.bbmt.2018.07.030","DOI":"10.1016\/j.bbmt.2018.07.030"},{"key":"10033_CR161","doi-asserted-by":"publisher","unstructured":"Markey, K. A., Schluter, J., Gomes, A. L. C., Littmann, E. R., Pickard, A. J., Taylor, B. P., \u2026 van den Brink, M. R. M. (2020). The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD. Blood, 136(1), 130\u2013136. https:\/\/doi.org\/10.1182\/blood.2019003369","DOI":"10.1182\/blood.2019003369"},{"key":"10033_CR162","doi-asserted-by":"publisher","unstructured":"Kaiko, G. E., Ryu, S. H., Koues, O. I., Collins, P. L., Solnica-Krezel, L., Pearce, E. J., \u2026 Stappenbeck, T. S. (2016). The colonic crypt protects stem cells from microbiota-derived metabolites. Cell, 167(4), 1137. https:\/\/doi.org\/10.1016\/j.cell.2016.10.034","DOI":"10.1016\/j.cell.2016.10.034"},{"key":"10033_CR163","doi-asserted-by":"publisher","unstructured":"Golob, J. L., DeMeules, M. M., Loeffelholz, T., Quinn, Z. Z., Dame, M. K., Silvestri, S. S., \u2026 Fredricks, D. N. (2019). Butyrogenic bacteria after acute graft-versus-host disease (GVHD) are associated with the development of steroid-refractory GVHD. Blood Advances. https:\/\/doi.org\/10.1182\/bloodadvances.2019000362","DOI":"10.1182\/bloodadvances.2019000362"},{"key":"10033_CR164","doi-asserted-by":"crossref","unstructured":"Weber, D., Hiergeist, A., Weber, M., Dettmer, K., Wolff, D., Hahn, J., \u2026 Holler, E. (2019). Detrimental effect of broad-spectrum antibiotics on intestinal microbiome diversity in patients after allogeneic stem cell transplantation: Lack of commensal sparing antibiotics. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 68(8), 1303\u20131310. Retrieved from https:\/\/academic.oup.com\/cid\/article-abstract\/68\/8\/1303\/5075542. Accessed 3 Jan 2022","DOI":"10.1093\/cid\/ciy711"},{"key":"10033_CR165","doi-asserted-by":"publisher","unstructured":"Child, J. A., Morgan, G. J., Davies, F. E., Owen, R. G., Bell, S. E., Hawkins, K., \u2026 Medical Research Council Adult Leukaemia Working Party. (2003). High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. The New England journal of medicine, 348(19), 1875\u20131883. https:\/\/doi.org\/10.1056\/NEJMoa022340","DOI":"10.1056\/NEJMoa022340"},{"key":"10033_CR166","doi-asserted-by":"publisher","unstructured":"Attal, M., Lauwers-Cances, V., Hulin, C., Leleu, X., Caillot, D., Escoffre, M., \u2026 IFM 2009 Study. (2017). Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma. The New England journal of medicine, 376(14), 1311\u20131320. https:\/\/doi.org\/10.1056\/NEJMoa1611750","DOI":"10.1056\/NEJMoa1611750"},{"key":"10033_CR167","doi-asserted-by":"publisher","unstructured":"Khan, N., Peled, J. U., Gomes, A. L. C., Devlin, S. M., Rondon-Clavo, C., Clurman, A., \u2026 van den Brink, M. R. M. (2018). Loss of microbiota diversity after autologous stem cell transplant is comparable to injury in allogeneic stem cell transplant. Blood, 132(Supplement 1), 608\u2013608. https:\/\/doi.org\/10.1182\/blood-2018-99-110857","DOI":"10.1182\/blood-2018-99-110857"},{"key":"10033_CR168","doi-asserted-by":"crossref","unstructured":"El Jurdi, N., Filali-Mouhim, A., & Salem, I. (2019). \u2026 in relative abundance, diversity and richness of the oral and gastrointestinal microbiome during autologous transplantation for multiple myeloma: Results of a \u2026. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. Retrieved from https:\/\/www.tctjournal.org\/article\/S1083-8791(18)31768-3\/abstract. Accessed 3 Jan 2022","DOI":"10.1016\/j.bbmt.2018.12.835"},{"key":"10033_CR169","doi-asserted-by":"publisher","unstructured":"Vuckovic, S., Minnie, S. A., Smith, D., Gartlan, K. H., Watkins, T. S., Markey, K. A., \u2026 Hill, G. R. (2019). Bone marrow transplantation generates T cell-dependent control of myeloma in mice. The Journal of clinical investigation, 129(1), 106\u2013121. https:\/\/doi.org\/10.1172\/JCI98888","DOI":"10.1172\/JCI98888"},{"key":"10033_CR170","doi-asserted-by":"publisher","unstructured":"Chung, D. J., Pronschinske, K. B., Shyer, J. A., Sharma, S., Leung, S., Curran, S. A., \u2026 Young, J. W. (2016). T-cell exhaustion in multiple myeloma relapse after autotransplant: Optimal timing of immunotherapy. Cancer Immunol Res, 4(1), 61\u201371. https:\/\/doi.org\/10.1158\/2326-6066.CIR-15-0055","DOI":"10.1158\/2326-6066.CIR-15-0055"},{"key":"10033_CR171","doi-asserted-by":"publisher","unstructured":"Lu, X., Ding, Z.-C., Cao, Y., Liu, C., Habtetsion, T., Yu, M., \u2026 Zhou, G. (2015). Alkylating agent melphalan augments the efficacy of adoptive immunotherapy using tumor-specific CD4+ T cells. Journal of immunology , 194(4), 2011\u20132021. https:\/\/doi.org\/10.4049\/jimmunol.1401894","DOI":"10.4049\/jimmunol.1401894"},{"key":"10033_CR172","doi-asserted-by":"publisher","unstructured":"Lee, D. H., Fung, T. T., Tabung, F. K., Marinac, C. R., Devore, E. E., Rosner, B. A., \u2026 Birmann, B. M. (2020). Prediagnosis dietary pattern and survival in patients with multiple myeloma. International journal of cancer. Journal international du cancer, 147(7), 1823\u20131830. https:\/\/doi.org\/10.1002\/ijc.32928","DOI":"10.1002\/ijc.32928"},{"issue":"10","key":"10033_CR173","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1093\/cid\/cir632","volume":"53","author":"E Gough","year":"2011","unstructured":"Gough, E., Shaikh, H., & Manges, A. R. (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clinical infectious diseases: An official publication of the Infectious Diseases Society of America, 53(10), 994\u20131002. https:\/\/doi.org\/10.1093\/cid\/cir632","journal-title":"Clinical infectious diseases: An official publication of the Infectious Diseases Society of America"},{"key":"10033_CR174","doi-asserted-by":"publisher","unstructured":"DeFilipp, Z., Peled, J. U., Li, S., Mahabamunuge, J., Dagher, Z., Slingerland, A. E., \u2026 Chen, Y. B. (2018). Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity. Blood Adv, 2(7), 745\u2013753. https:\/\/doi.org\/10.1182\/bloodadvances.2018017731","DOI":"10.1182\/bloodadvances.2018017731"},{"key":"10033_CR175","doi-asserted-by":"publisher","unstructured":"Taur, Y., Coyte, K., Schluter, J., Robilotti, E., Figueroa, C., Gjonbalaj, M., \u2026 Xavier, J. B. (2018). Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant. Science translational medicine. https:\/\/doi.org\/10.1126\/scitranslmed.aap9489","DOI":"10.1126\/scitranslmed.aap9489"},{"key":"10033_CR176","doi-asserted-by":"publisher","unstructured":"Kakihana, K., Fujioka, Y., Suda, W., Najima, Y., Kuwata, G., Sasajima, S., \u2026 Ohashi, K. (2016). Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut. Blood, 128(16), 2083\u20132088. https:\/\/doi.org\/10.1182\/blood-2016-05-717652","DOI":"10.1182\/blood-2016-05-717652"},{"key":"10033_CR177","doi-asserted-by":"publisher","unstructured":"van Lier, Y. F., Davids, M., Haverkate, N. J. E., de Groot, P. F., Donker, M. L., Meijer, E., \u2026 Hazenberg, M. D. (2020). Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients. Science translational medicine, 12(556). https:\/\/doi.org\/10.1126\/scitranslmed.aaz8926","DOI":"10.1126\/scitranslmed.aaz8926"},{"key":"10033_CR178","doi-asserted-by":"publisher","unstructured":"Spindelboeck, W., Schulz, E., Uhl, B., Kashofer, K., Aigelsreiter, A., Zinke-Cerwenka, W., \u2026 Neumeister, P. (2017). Repeated fecal microbiota transplantations attenuate diarrhea and lead to sustained changes in the fecal microbiota in acute, refractory gastrointestinal graft-versus-host-disease. Haematologica, 102(5), e210\u2013e213. https:\/\/doi.org\/10.3324\/haematol.2016.154351","DOI":"10.3324\/haematol.2016.154351"},{"key":"10033_CR179","doi-asserted-by":"publisher","unstructured":"DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., \u2026 Hohmann, E. L. (2019). Drug-resistant E. coli bacteremia transmitted by fecal microbiota transplant. The New England journal of medicine, 381(21), 2043\u20132050. https:\/\/doi.org\/10.1056\/NEJMoa1910437","DOI":"10.1056\/NEJMoa1910437"}],"container-title":["Cancer and Metastasis Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-022-10033-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10555-022-10033-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10555-022-10033-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T11:23:02Z","timestamp":1660044182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10555-022-10033-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,29]]},"references-count":179,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10033"],"URL":"https:\/\/doi.org\/10.1007\/s10555-022-10033-7","relation":{},"ISSN":["0167-7659","1573-7233"],"issn-type":[{"value":"0167-7659","type":"print"},{"value":"1573-7233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,29]]},"assertion":[{"value":"3 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}